Kaiser Permanente-Anaheim — Anaheim, California

Public research footprint of Kaiser Permanente-Anaheim, compiled from the ClinicalTrials.gov public registry.

159

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Botryoid-Type Embryonal Rhabdomyosarcoma · Stage IB Lung Non-Small Cell Carcinoma AJCC v7 · Recurrent Ovarian Carcinoma · Metastatic Non-Cutaneous Melanoma

Recently updated registry entries

NCT02196181 — Testing Two Different Treatment Schedules of Dabrafenib and Trametinib for Skin Cancer… (Active Not Recruiting)
NCT04671667 — Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself… (Recruiting)
NCT02506153 — Physician/Patient Choice of Either High-Dose Recombinant Interferon Alfa-2B or… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Kaiser Permanente-Anaheim?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.